Exploring the Future of Rare Bleeding Disorder Treatment at EHC 2026
European Haemophilia Consortium (EHC) shared a post on LinkedIn:
“Reminder to EHC National Member Organisations (NMOs): registration for the EHC New Technologies Conference 2026 is still open!
Joining us in Bucharest, Romania, from 30 October to 1 November 2026, this conference will bring together EHC NMOs and healthcare professionals for an in-depth look at the latest medical advancements in rare bleeding disorders, including the new technologies set to reach the European market in the coming years.
Places are limited to two representatives per NMO on a first-come, first-served basis.
EHC will cover registration, travel (economy fare), and accommodation costs for participants nominated by NMOs.
The registration link has been sent directly to NMOs by email.
Haven’t registered yet?
Act now — spots are filling up!
Full event details.”
Stay updated with Hemostasis Today.
-
Nov 16, 2026, 09:47Ankit Kumar: A Memorable Experience at Haematocon 2026
-
Nov 15, 2026, 23:44Pablo César Spada: Prevention of Venous Thromboembolism After Total Hip or Knee Replacement
-
Nov 15, 2026, 23:30Eshal Amir: Factor XI Inhibitors in AFib and Aortic Mortality Trends
-
Nov 15, 2026, 23:19Hamza Bashir: Adding Endovascular Therapy to Anticoagulation Cuts Moderate-to-Severe PTS in Half
-
Nov 15, 2026, 23:06Lanre Tunji-Ajayi: 2 Days of Deliberative Dialogue Hosted by the Network of Rare Blood Disorder Organizations
-
Nov 15, 2026, 23:00Fanny Delettre: Looking Back at Volunteer Blood Donor Friends Day
-
Nov 15, 2026, 20:56Victoria Adedoyin Adisa-Thomas: What I Learned About SCD During My Genetic Counselling Rotation
-
Nov 15, 2026, 20:55Martin Holst Lange: One Step Closer to a Potential New Treatment for Sickle Cell Disease
-
Nov 15, 2026, 20:53Bontha Babu: Health-Related Quality of Life Among Adults with Sickle Cell Disease in India